The article titled “The Short Form 6 Dimensions (SF-6D): Development and Evolution” offers a comprehensive review of the SF-6D, a preference-based measure derived from the SF-36 and SF-12 health surveys, used to generate health utility values and inform cost-utility analyses across healthcare interventions.
One of the core contributions of this article is to systematically chart the historical development and methodological evolution of the SF-6D instrument. The authors explain that the original version (SF-6Dv1) was developed in the 1990s to convert SF-36 responses into health utility values, enabling the calculation of QALYs (quality-adjusted life years) without collecting additional data. The classification comprised six dimensions—physical functioning, role limitations, social functioning, pain, mental health, and vitality—each derived from a subset of SF-36 items (Mukuria et al., 2024).
The article then describes how criticisms of the original SF-6Dv1—such as illogical ordering of levels, floor effects, and the complexity of standard gamble (SG) valuation—prompted the creation of SF-6Dv2, an updated and refined version. SF-6Dv2 featured psychometric improvements, more logically ordered dimensions, harmonized negative wording across items, and the adoption of discrete choice experiment (DCE) methods with duration for valuation, which facilitated broader international application and online data collection (Mukuria et al., 2024).
A key proposition of the paper is that SF-6Dv2 addresses limitations of its predecessor both at the measurement and valuation levels, leading to more sensitive, logically consistent, and internationally adaptable utility estimates. The standalone SF-6Dv2 Health Utility Survey (HUS) version is highlighted as a significant innovation, offering reduced patient burden without the need for the full SF-36 or SF-12 instruments.
Another central argument is the importance of country-specific value sets and the utility of Bayesian modelling in deriving more accurate estimates, particularly in low- and middle-income settings with limited data. The paper emphasizes the role of SF-6D in complementing generic measures like EQ-5D and HUI, noting its comparative strength in covering fatigue and providing linked profile-preference measures for QALY estimation.
Finally, the article recommends the use of SF-6Dv2 where possible due to improved validity and broader applicability, while also acknowledging the need for more psychometric validation in diverse populations and further research to link SF-6Dv1 and SF-6Dv2 scores for longitudinal comparability.
Reference: Mukuria, C., Rowen, D., Mulhern, B., McDool, E., Kharroubi, S., Bjorner, J. B., & Brazier, J. E. (2024). The Short Form 6 Dimensions (SF‑6D): Development and Evolution. Applied Health Economics and Health Policy, 23, 19–33. https://doi.org/10.1007/s40258-024-00919-8
Podcast Link: https://notebooklm.google.com/notebook/b087aa78-ee50-40d5-8282-da1dd611bdfa/audio